PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30280784-0	2018	Jagged2 promotes cancer stem cell properties of triple negative breast cancer cells and paclitaxel resistance via regulating microRNA-200.	Paclitaxel	88-98	jagged canonical Notch ligand 2	Homo sapiens	0-7	
30280784-4	2018	Jagged2 expression in paclitaxel-resistant group and non-resistance group before and after treatment was detected by quantitative Real-time-polymerase chain reaction (qRT-PCR), respectively.	Paclitaxel	22-32	jagged canonical Notch ligand 2	Homo sapiens	0-7	
30280784-5	2018	After Jagged2 knockdown in paclitaxel-resistant MDA-MB-231 cells (MDA-MB-231/TXR), expression of CD44+CD24-ESA+ subset was detected by flow cytometry.	Paclitaxel	27-37	jagged canonical Notch ligand 2	Homo sapiens	6-13	
30280784-7	2018	RESULTS: Jagged2 was highly expressed in paclitaxel-resistant TNBC tissues and cells.	Paclitaxel	41-51	jagged canonical Notch ligand 2	Homo sapiens	9-16	
30280784-9	2018	Knockdown of Jagged2 inhibited CSC properties and paclitaxel resistance, whereas upregulated microRNA-200 expression.	Paclitaxel	50-60	jagged canonical Notch ligand 2	Homo sapiens	13-20	
30280784-10	2018	The inhibited CSC properties and paclitaxel resistance induced by Jagged2 knockdown were reversed by microRNA-200 knockdown.	Paclitaxel	33-43	jagged canonical Notch ligand 2	Homo sapiens	66-73	
30280784-11	2018	CONCLUSIONS: Jagged2 maintains CSC properties of TNBC cells and paclitaxel resistance via regulating microRNA-200.	Paclitaxel	64-74	jagged canonical Notch ligand 2	Homo sapiens	13-20